MIXIF yields 3.20% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, MIXIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MIXIF + PFE for your $10,000?
mixi, Inc. engages in the entertainment and lifestyle businesses in Japan. It offers Monster Strike, Kotodaman, and Monster Strike Stadium gaming applications; TIPSTAR, a freemium online betting app; Chariloto, a keirin and auto race betting ticket sales site; Chiba Jets Funabashi; netkeiba.com, a national horse racing resource; and Weekly Baseball Online, a baseball information site. The company also provides FamilyAlbum, a family photo and video sharing app; minimo, a salon artist booking app; mixi, a social networking service that offers space for friendly communication; KARASTA, a karaoke video community; Find Job!, a job recruitment info site for the IT and web industries; and OKURU, a photo gift service. It also provides employment opportunities for people with disabilities; operates XFLAG stores that offer merchandise from game; organizes events; and produces and sells various goods, as well as manages professional sports team, and businesses related to publicly operated competitions and other services. Mixi Inc. offers social networking services that focuses on digital entertainment business, sports business, and lifestyle business. It allows users to connect with their friends. The company was formerly known as eMecury Co., Ltd. and changed its name to mixi, Inc. in February 2006. mixi, Inc. was founded in 1999 and is headquartered in Tokyo, Japan.
Full MIXIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.